Galderma Releases Data From Rosacea Trial

Results from ORCA, a community-based study of 1,421 patients with mild to severe papulopustular rosacea (PPR), found that in patients suffering from PPR, Oracea (doxycycline 40 mg) effectively reduces rosacea pustules and papules when used as a monotherapy treatment or when added on to other topical rosacea therapies.
NewsBlaze